Immune response to natural and recombinant antigens of Helicobacter pylori in patients with dyspeptic complaints

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 9, 1999, Pages 636-642

  Graessle, S ^a   Grabher, G ^a   Gapp, G ^a   Preuss, E ^a   Datz, C ^b   Sandhofer, F ^b   Stoffler G ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b St Johanns Spital   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CELL SURFACE PROTEIN; RECOMBINANT PROTEIN; UREASE;

ARTICLE; BLOOD SAMPLING; CELL LYSATE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DUODENUM ULCER; DYSPEPSIA; ENZYME IMMUNOASSAY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; RELIABILITY; STOMACH ULCER;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; RECOMBINANT PROTEINS;

EID: 0032757526     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050364     Document Type: Article

References (36)

1. 1. Blaser M, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A: Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Research (1995) 55:2111-2115
2. 2. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N, Rappuoli R: Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proceedings of the National Academy of Science of the United States of America (1993) 90:5791-5795
3. 3. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Schubert TT: Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. New England Journal of Medicine (1989) 321:1562-1566
4. 4. Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez GI, Schubert TT: Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology (1995) 109:136-141
5. 5. Cullen DNJ, Collins BJ, Christiansen KJ, Epis J, Warren JR, Surveyor I, Cullen KJ: When is Helicobacter pylori infection acquired? Gut (1993) 34:1681-1682
6. 6. Mitchell HM, Hazell SL, Li YY, Hu PJ: Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. American Journal of Gastroenterology (1996) 91:1785-1788
7. 7. Sipponen P, Varis K, Fraki O, Korri UM, Seppala K, Siurala M: Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis: A clinical follow up study of 454 outpatients. Scandinavian Journal of Gastroenterology (1990) 25:966-973
8. 8. Dunn BE: Pathogenic mechanisms of Helicobacter pylori. Gastroenterology Clinics of North America (1993) 22:43-57
9. 9. Lee A, Fox J, Hazell S: Pathogenicity of Helicobacter pylori: a perspective. Infection & Immunity (1993) 61:1601-1610
10. 10. Telford JL, Covacci A, Ghiara P, Montecucco C, Rappuoli R: Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential new therapies and vaccines. Trends in Biotechnology (1994) 12:420-426
11. 11. Cover TL, Blaser MJ: Purification and charaterization of the vacuolating toxin from Helicobacter pylori. Journal of Biological Chemistry (1992) 267:10570-10575
12. 12. Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno RA, Russi M, Quaranta S: Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. Journal of Clinical Microbiology (1989) 27:225-226
13. 13. Ghiara P, Marchetti M, Blaser MJ, Tummuru MKR, Cover TL, Segal ED, Tompkins LS, Rappuoli R: Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infection & Immunity (1995) 63:4154-4160
14. 14. Leunk RD, Ferguson MA, Morgan DR, Low DE, Simor AE: Antibody to cytotoxin in infection by Helicobacter pylori. Journal of Clinical Microbiology (1990) 28:1181-1184
15. 15. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR: Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. Journal of Medical Microbiology (1988) 26:93-99
16. 16. Telford JL, Ghiara P, DellÓrco M, Comanducci M, Burroni D, Bugnoli M, Tecce MF, Censini S, Covacci A, Xiang Z, Papini E, Montecucco C, Parente L, Rappuoli R: Gene structure of Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. Journal of Experimental Medicine (1994) 179:1653-1658
17. 17. Tummuru MK, Cover TL, Blaser MJ: Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infection & Immunity (1993) 61:1799-1809
18. 18. Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MKR, Perez-Perez GI, Blaser MJ: Serological detection with cagA + Helicobacter pylori strains. Journal of Clinical Microbiology (1995) 33:1496-1500
19. 19. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, Covacci A: Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infection & Immunity (1995) 63:94-98
20. 20. Ricci V, Ciacci C, Zarrilli R, Sommi P, Tummuru MKR, Del Vecchio Blanco C, Bruni CB, Cover TL, Blaser MJ, Romano M: Effect of Helicobacter pylori: on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infection & Immunity (1996) 64:2829-2833
21. 21. Cover TL, Dooley CP, Blaser MJ: Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infection & Immunity (1990) 58:603-610
22. 22. Crabtree JE, Taylor JD, Wyatt JI, Hestdey RV, Shallcross TM, Tompkins DS, Rathbone BJ: Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet (1991) 338:332-335
23. 23. Klaamas K, Held M, Wadström T, Lipping A, Kurtenkov O: IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. International Journal of Cancer (1996) 67:1-5
24. 24. Bazillou M, Fendri C, Castel O, Ingrand P, Fauchére JL: Serum antibody response to the superficial and released components of Helicobacter pylori. Clinical & Diagnostic Laboratory Immunology (1994) 1:310-317
25. 25. Mitchell HM, Lee A: Are there ulcerogenic strains of Helicobacter pylori? Scandinavian Journal of Gastroenterology (1994) 29:1-5
26. 26. Nilson I, Ljungh A, Aleljung P, Wadström T: Immunoblot assay for serodiagnosis of Helicobacter pylori infections. Journal of Clinical Microbiology (1997) 35:427-432
27. 27. Vijayakumari S, Khin MM, Jiang B, Ho B: The pathogenic role of the coccoid form of Helicobacter pylori. Cytobiosis (1995) 82:251-260
28. 28. Kuipers EJ, Pena AS, van Kamp G, Uyterlinde AM, Pals G, Pels NFM, Kurz-Polemann E, Meuwissen SGM: Seroconversion for Helicobacter pylori. Lancet (1993) 342:328-331
29. 29. Schaber E, Umlauft F, Stöffler G, Aigner F, Paulweber B, Sandhofer F: Indirect immunofluorescence test and enzyme-linked immunosorbent assay for detection of Campylobacter pylori. Journal of Clinical Microbiology (1989) 27:327-330
30. 30. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 227:680-685
31. 31. Andersen LP, Espersen F: Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique. Journal of Clinical Microbiology (1992) 30:1743-1751
32. 32. Chatha L, Ray P, Bhasin DK, Panigahi D, Khanna T, Vaiphei K, Singh K, Singh H: Western blot analysis of serological response in Helicobacter pylori in acid peptic diseases. Indian Journal of Medical Research (1997) 105:170-175
33. 33. Crabtree JE, Wyatt JI, Sobala GM, Miller G, Tomkins DS, Primrose JN, Morgan AG: Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 34:1339-1343
34. 34. Takata T, Fujimoto S, Anzai K, Shirotani T, Okada M, Sawae Y, Ono J: Analysis of the expression of CagA and VacA and the vacuolating activity in 167 isolates from patients with either peptic ulcers or non-ulcer dyspepsia. American Journal of Gastroenterology (1998) 93:30-34
35. 35. Graham DY, Genta RM, Graham DP, Crabtree JE: Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. Journal of Clinical Pathology (1996) 49:829-832
36. 36. Yang JC, Wang TH, Wang HJ, Kuo CH, Wang JT, Wang WC: Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in Helicobacter pylori strains isolated from Taiwanese patients. American Journal of Gastroenterology (1997) 92:1316-1321